Literature DB >> 10857489

Results after nonsurgical local treatment of primary liver malignancies.

G M Hargreaves1, R Adam, H Bismuth.   

Abstract

Although it is generally agreed that surgical resection is the only curative treatment for liver malignancy, this is not possible in all cases. In situ methods for destruction of liver tumors are now available. We describe recently developed methods, with an up-date based on the literature and our own experience. Under ultrasound guidance chemical agents such as ethanol, hot saline, and acetic acid may be injected into the tumor, or thermally mediated techniques involving cryotherapy, microwaves, radiofrequency, or interstitial laser photocoagulation may be applied. Also, various ways of delivering radiotherapy to primary liver cancer have been developed. Although there are few randomized studies to compare these local, nonsurgical techniques, they have been shown to improve survival and in some cases to render tumors resectable. The long-term results will show the real benefits of these newer treatments, particularly in high-risk patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10857489     DOI: 10.1007/s004230050263

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  4 in total

1.  Hemolysis as a complication of radiofrequency ablation for hepatocellular carcinoma must be paid more attention.

Authors:  Hongyu Li; Bo Li; Yonggang Wei; Fei Liu
Journal:  Dig Dis Sci       Date:  2011-11       Impact factor: 3.199

Review 2.  Effect of liver regeneration on malignant hepatic tumors.

Authors:  Ji-Hua Shi; Pål-Dag Line
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

3.  A deformable model for tracking tumors across consecutive imaging studies.

Authors:  Gabriela Niculescu; John L Nosher; M D Benjamin Schneider; David J Foran
Journal:  Int J Comput Assist Radiol Surg       Date:  2009-06       Impact factor: 2.924

Review 4.  Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges.

Authors:  Hsuan Yeh; Chung-Cheng Chiang; Tzung-Hai Yen
Journal:  World J Gastroenterol       Date:  2021-07-14       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.